Summary
The proposal aims to reduce the administrative burden on manufacturers of medical devices and in vitro diagnostics, particularly for small businesses. It seeks to improve efficiency while maintaining high safety standards through better transparency and oversight. 10 30.06.2026
Other
health
industry
administrative law
public administration
information technology and data processing
Key points
- The proposal aims to significantly reduce the administrative and financial burdens on small and medium-sized enterprises (SMEs).
- Certificate validity could be extended indefinitely following a successful re-assessment, providing more certainty for manufacturers.
- Fee reductions are proposed for micro-enterprises and producers of orphan or breakthrough devices to ensure market access.
- Safety and performance summaries must be written in plain language so that patients can easily understand them.
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.